MDS-276 Management of Patients with Lower-Risk Myelodysplastic Syndromes (LR-MDS) in a Large US Community Oncology Practice: A Focus on Patient Outcomes Post Erythropoiesis-Stimulating Agent (ESA) Treatment

Autor: Fonseca, Gustavo, Warner, Amanda, Ming, Amy, Slaff, Samantha, Tang, Derek, Singh, Nisha, Gavrilov, Svetlana, Swanson, Ashley, Lobo, Francis, Heritage, Trevor, Griffin, Ernest, Gordan, Lucio
Zdroj: In Clinical Lymphoma, Myeloma and Leukemia September 2024 24 Supplement 1:S390-S391
Databáze: ScienceDirect
Externí odkaz: